TAM
SAGE

Tocqueville Asset Management’s Sage Therapeutics SAGE Stock Holding History

Tocqueville Asset Management’s Portfolio SAGE Stock Details SAGE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-2,875
Closed -$208K – 705
2019
Q4 		$208K Sell
2,875
-46,990
-94% -$5.78M ﹤0.01% 700
2019
Q3 		$7M Sell
49,865
-11,880
-19% -$1.99M 0.09% 216
2019
Q2 		$11.3M Sell
61,745
-780
-1% -$133K 0.15% 176
2019
Q1 		$9.95M Sell
62,525
-19,360
-24% -$2.8M 0.13% 186
2018
Q4 		$7.84M Sell
81,885
-4,565
-5% -$522K 0.12% 194
2018
Q3 		$12.2M Sell
86,450
-10,845
-11% -$1.67M 0.15% 171
2018
Q2 		$15.2M Buy
97,295
+40,940
+73% +$6.43M 0.19% 137
2018
Q1 		$9.08M Buy
56,355
+19,055
+51% +$3.24M 0.12% 194
2017
Q4 		$6.14M Sell
37,300
-21,600
-37% -$2.09M 0.07% 278
2017
Q3 		$3.67M Sell
58,900
-12,550
-18% -$986K 0.04% 370
2017
Q2 		$5.69M Buy
71,450
+10,400
+17% +$752K 0.07% 276
2017
Q1 		$4.34M Sell
61,050
-2,000
-3% -$117K 0.05% 312
2016
Q4 		$3.22M Buy
63,050
+18,675
+42% +$880K 0.04% 352
2016
Q3 		$2.04M Buy
44,375
+4,850
+12% +$197K 0.02% 407
2016
Q2 		$1.19M Hold
39,525
– – 0.01% 484
2016
Q1 		$1.27M Buy
39,525
+650
+2% +$22.9K 0.02% 467
2015
Q4 		$2.27M Buy
38,875
+5,775
+17% +$286K 0.03% 401
2015
Q3 		$1.4M Buy
33,100
+10,400
+46% +$641K 0.02% 492
2015
Q2 		$1.66M Buy
22,700
+6,325
+39% +$407K 0.02% 485
2015
Q1 		$823K Buy
+16,375
New +$704K 0.01% 621

Other funds holding SAGE

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
GPP
Great Point Partners Greenwich, Connecticut $529M AUM 337.4% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.75B AUM 68.58% 1-Year Est. Return

Tocqueville Asset Management's SAGE Position: Q1 2020 in Review

Tocqueville Asset Management sold out of Sage Therapeutics (SAGE) in Q1 2020, closing a stake of 2,875 shares — an estimated $208K sold.

Tocqueville Asset Management first reported a position in SAGE in Q1 2015 and held it in 20 quarters. The position peaked at $15.2M in Q2 2018. 230 funds tracked by Wall St. Rank hold SAGE as of Q1 2020.

  • Tocqueville Asset Management reported no remaining Sage Therapeutics position as of Q1 2020 after selling out during the quarter.
  • Tocqueville Asset Management sold 2,875 Sage Therapeutics shares in Q1 2020, an estimated $208K.
  • Tocqueville Asset Management first reported a position in Sage Therapeutics in Q1 2015 and held it in 20 quarters.
  • Tocqueville Asset Management's Sage Therapeutics position peaked at $15.2M in Q2 2018.
  • 230 funds tracked by Wall St. Rank held Sage Therapeutics as of Q1 2020.

Based on Tocqueville Asset Management's 13F filing for Q1 2020, filed 15 May 2020.